Sample Content Elements

You’ve chosen a terrific way of integrating images and text into your website. Move the image anywhere you want in this container and the text will automatically wrap around it. You can display events team members new products and more easily and creatively. To start add an image from the Image Picker and edit it as you would edit any image in the system. For example you can link the image to existing pages in your site a website URL a popup or an anchor. After you’ve chosen the image add your text. You can add text that describes the image you’ve selected or simply use the image for decorative purposes. \nYou’ve chosen a terrific way of integrating images and text into your website. Move the image anywhere you want in this container and the text will automatically wrap around it. You can display events team members new products more easily and creatively. To start add an image from the Image Picker and edit it as you would edit any image in the system. For example you can link the image to existing pages in your site a website URL a popup or an anchor. After you’ve chosen the image add your text. You can add text that describes the image you’ve selected or simply use the image for decorative purposes.

  • Title or question
    Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.
  • Title or question
    Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.
  • Title or question
    Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata

Click Here

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata

Click Here

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata

Click Here

Hello World. A heart filled with love has no room for hate.


1

Our Vision

Do not pass by someone in need. When you join our congregation, you join a community fed by love and hope, one in which everyone is welcome. Join us and discover the power of prayer, faith and humility. 

2

Our Vision

Love thy neighbor as thyself. This is not only a central tenant of Christianity, it may be the one that guides all else. To treat others with respect, kindness, and love is what we strive for, every day, in everything we do. 

3

Our Vision

You don’t need a reason to help. All you need is opportunity. Together, we'll find places where our assistance would be most appreciated and we offer help, guidance, companionship and love. 

4

Our Vision

Your life is your message to the world. Fill it with meaning and hope, with love for the Lord and with compassion for all of the Lord's children. You are never alone when the Lord is with you, and He is always with you.  

Welcome!


Pastor Wright is passionate about reaching people through the love of God. He sees the Lord in all aspects of life, and conveys his deep faith through sermons, classes, and actions. Pastor Wright was ordained at the Bible College in 2001. His passion for Scripture is unmistakable, and conveyed through every activity that he undertakes. Pastor Wright holds several Bible Classes every week, all of which are open to the public. Join us to discover the full meaning of the Lord's words, and how they can enrich your life. 


New Line of Copy

JOIN US

Faith


Faith is the cornerstone of our church. It is part of every activity that we do, every meeting that we hold. We believe in our Lord, and that our actions are a reflection of his goodness. 

Scripture


We look to the Lord for guidance in our lives. In Scripture, we find all that we need to guide us in the right path. Reading and understand Scripture helps us all live meaningful lives. 

Community


Join us. We welcome each and every one of you to encounter the Lord's unconditional love with us. Inside each of us is a purpose and meaning to be fulfilled by God. 

Youth Ministry


Youth is a unique period of life, one filled with exploration, discovery, excitement and fulfillment. The Church Youth Ministry provides a nurturing, loving environment for young people exploring the world. It is a safe place where faith guides exploration and self-discovery. 

OUR NEWS

Children's Ministry


The Gospel has a message for everyone, of every age, and in every language. Exposing your child to the Lord's path when they are young gives them guidance, hope and strength that lasts a lifetime. To learn more, be in touch with one of our Pastors.  
CONTACT US

Our Team


Lorem Ipsum

Mauris molestie tincidunt gravida. Suspendisse in ullamcorper dui, id varius dolor. Vivamus non placerat velit. Donec vel enim at neque blandit ultrices. Nulla ornare porttitor lectus. Pellentesque eget nibh tellus. Ut dapibus ultricies dui vel fermentum. Phasellus a neque auctor, rutrum elit mattis, vehicula neque. Etiam lectus odio, aliquam nec elit vitae, mattis pulvinar dolor. Pellentesque interdum, sapien in rutrum congue, mauris felis bibendum tortor, ut lobortis tortor purus feugiat lorem. Suspendisse potenti.

Lorem Ipsum

1

Our Vision

Add new Copy

2

Our Vision

Love thy neighbor as thyself. This is not only a central tenant of Christianity, it may be the one that guides all else. To treat others with respect, kindness, and love is what we strive for, every day, in everything we do. 

15


lorem ipsum

 0%


lorem ipsum

500+


lorem ipsum

3


lorem ipsum

You can make the difference!

Recent Posts


By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance September 23, 2016
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. Send an Action Alert to your Members of Congress Today! Why do we need this action now? The last decade has seen an explosion in […] The post Action Alert: Oral Chemotherapy Parity appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance September 21, 2016
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report here, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible. The post Report from the Biennial Ovarian Cancer Research Symposium appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund August 16, 2016
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund August 1, 2016
(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund July 28, 2016
(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in […] 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance July 26, 2016
Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you […] The post Research Study: Meditation appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund July 18, 2016
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund July 7, 2016
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and […] 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance July 5, 2016
Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well […] The post Listen Now: Research Updates from 2016’s Top Medical Meetings appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund June 23, 2016
(June 23, 2016) The Journal of Clinical Oncology recently published a study on the role of oral contraceptives (OC) on ovarian cancer prevention. The study, which analyzed data from 21 studies with 5, 584 cases of ovarian cancer, concluded that OC reduced the risk of a variety of invasive ovarian cancers. The risk of developing […] 
Show More
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance September 23, 2016
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. Send an Action Alert to your Members of Congress Today! Why do we need this action now? The last decade has seen an explosion in […] The post Action Alert: Oral Chemotherapy Parity appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance September 21, 2016
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report here, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible. The post Report from the Biennial Ovarian Cancer Research Symposium appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund August 16, 2016
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society […] 
More Posts

Upcoming Events


  • 4 JUL - Summer BBQ

    Describe the event in full, including time, location, what to bring, and who is the intended audience. 


  • 7 JUL - Ministry Potluck

    Describe the event in full, including time, location, what to bring, and who is the intended audience. 


  • 12 JUL - Family Night

    Describe the event in full, including time, location, what to bring, and who is the intended audience. 


  • 16 JUL - Outreach Planning

    Describe the event in full, including time, location, what to bring, and who is the intended audience. 


Volunteer


  • How can I volunteer?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

  • Can I bring friends to volunteer with me?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

  • Where do you volunteer?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

  • Do you have long-term volunteer positions?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

GET IN TOUCH

Donate


  • How can I donate?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

  • What type of donations do you accept?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

  • Can I donate services?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

  • Is there a tax deduction for donations?

    Write the answer to the question here. You can emphasize this text with bullets, italics or bold, and add links.

New Button

Send us a Message


Contact info


Address:

Street Address

City, Country, Zip Code

Email:

mymail@mailservice.com

Phone:

(555) 555-5555

  • How is ovarian cancer diagnosed?
    • A vaginal-rectal pelvic examination (also called a bimanual exam) – This exam allows the ovaries to be examined from many sides. Every woman should undergo a rectal and vaginal pelvic examination at her checkup with her gynecologist.
    • Transvaginal Ultrasound - This test uses sound waves to create a picture of the ovaries, and can often reveal if there are masses or irregularities on the surface of the ovaries. It cannot determine if you have cancer but it can show characteristics that give different levels of suspicion.
    • CA125 blood test - This test measures the level of a protein in the blood that may increase when a cancerous tumor is present. This protein is produced by ovarian cancer cells and is elevated in more than 80% of women with advanced ovarian cancers and 50% of those with early-stage cancers. CA125 is present in half of early cancers and can be elevated in benign conditions. The National Cancer Institute (NCI) does not endorse using it to screen women at ordinary risk or in the general population.
    • It is very important to note that none of these tests are definitive when used on their own. They are most effective when used in combination with each other. The only way to confirm the presence of ovarian cancer suspected by the above tests is through a surgical biopsy of the tumor tissue.
    • The PAP test is used to detect cervical cancer, NOT ovarian cancer.

  • If tests suggest the possibility of ovarian cancer, seek a referral to a gynecologic oncologist:
    • A gynecologic oncologist is a physician who specializes in treating women with reproductive tract cancers.
    • Gynecologic oncologists are initially trained as obstetrician/gynecologists and then undergo three to four years of specialized education in all of the effective forms of treatment for gynecologic cancers (surgery, radiation, chemotherapy and experimental treatments) as well as the biology and pathology of gynecologic cancers.
  • Why is it so important to be treated by a gynecologic oncologist?

    The importance of being treated by a gynecologic oncologist cannot be stressed enough. According to numerous medical studies, there are significant survival advantages for women who are treated, managed, and operated on by a gynecologic oncologist.


    • Gynecologic oncologists are 5 times more likely to completely remove ovarian tumors during surgery
    • 80% of ovarian cancer patients receive inadequate surgical debulking and staging from non-gynecologic oncology surgeons
    • Survival rate and outcomes vastly improve with a gynecologic oncologist
  • How can I find a gynecologic oncologist in my area?

    Visit The Foundation for Women's Cancer online at https://www.foundationforwomenscancer.org/

  • How is ovarian cancer usually treated?
    • Surgery, debulking, and surgical staging (removal of ovarian tumors)
    • Chemotherapy
    • Radiation therapy when appropriate
    • Treatment for recurrent ovarian cancer needs to be determined by a gynecologic oncologist
  • Clinical Trials
    • You may be asked to participate in a clinical trial. The purpose of the clinical trial is to determine whether a new treatment is effective for ovarian cancer.  
    • Clinical trials are divided into three phases:  (Phase 1) Is to determine a dose range for the particular drug; (Phase 2) is to determine the response of the drug; and (Phase 3) to evaluate a large group of women with ovarian cancer to determine the effectiveness of the drug. 
    • Radiation therapy when appropriate
    • Treatment for recurrent ovarian cancer needs to be determined by a gynecologic oncologist
  • Where can I get more information and help?

Our Calling 


Every member of our Church has come with a calling. To bring love and faith, to heal and to listen, to find meaning in the world and to help discover meaning in this gift of life. Our calling is your calling. We are one with the Lord. 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance September 23, 2016
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. Send an Action Alert to your Members of Congress Today! Why do we need this action now? The last decade has seen an explosion in […] The post Action Alert: Oral Chemotherapy Parity appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance September 21, 2016
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report here, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible. The post Report from the Biennial Ovarian Cancer Research Symposium appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund August 16, 2016
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund August 1, 2016
(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund July 28, 2016
(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in […] 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance July 26, 2016
Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you […] The post Research Study: Meditation appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund July 18, 2016
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. […] 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund July 7, 2016
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and […] 
By By: Ovarian Cancer National Alliance | Source: Ovarian Cancer National Alliance July 5, 2016
Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well […] The post Listen Now: Research Updates from 2016’s Top Medical Meetings appeared first on Ovarian Cancer National Alliance. 
By By: Ovarian Cancer Research Fund | Source: Ovarian Cancer Research Fund June 23, 2016
(June 23, 2016) The Journal of Clinical Oncology recently published a study on the role of oral contraceptives (OC) on ovarian cancer prevention. The study, which analyzed data from 21 studies with 5, 584 cases of ovarian cancer, concluded that OC reduced the risk of a variety of invasive ovarian cancers. The risk of developing […] 

Header 1

Header 2

Header 3

Header 4

Header 5
Header 6
Share by: